Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:1901796; regulation of signal transduction by p53 class mediator | 4.462E-08 | 1.388E-04 | AURKA, AURKB, BLM, CDK2, L3MBTL1 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 5.300E-06 | 2.684E-03 | CYP2C19, CYP3A4 |
BP | GO:0009987; cellular process | GO:0006977; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.787E-06 | 3.102E-03 | AURKA, CDK1, CDK2 |
BP | GO:0032502; developmental process | GO:0031100; animal organ regeneration | 1.255E-05 | 4.392E-03 | AURKA, CDK1, CDK4 |
BP | GO:0009987; cellular process | GO:0000733; DNA strand renaturation | 1.271E-05 | 4.392E-03 | BLM, RECQL |
BP | GO:0008152; metabolic process | GO:0031145; anaphase-promoting complex-dependent catabolic process | 1.465E-05 | 4.748E-03 | AURKA, AURKB, CDK1 |
BP | GO:0065007; biological regulation | GO:0051338; regulation of transferase activity | 1.483E-05 | 4.748E-03 | AURKB, BLM, CDK1, CDK2, CDK4, MAPT |
BP | GO:0009987; cellular process | GO:0035690; cellular response to drug | 2.007E-05 | 5.987E-03 | BLM, CDK1, CDK2, CDK4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 2.327E-05 | 6.581E-03 | CYP2C19, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0035404; histone-serine phosphorylation | 2.327E-05 | 6.581E-03 | AURKA, AURKB |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.328E-04 | 1.494E-03 | CYP3A4; CYP2C19 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 7.571E-04 | 5.678E-03 | CYP3A4; CYP2C19 |
hsa04110 | Cell cycle_Homo sapiens_hsa04110 | 4.913E-05 | 7.369E-04 | CDK4; CDK2; CDK1 |
hsa04114 | Oocyte meiosis_Homo sapiens_hsa04114 | 4.796E-05 | 7.369E-04 | CDK2; CDK1; AURKA |
hsa04115 | p53 signaling pathway_Homo sapiens_hsa04115 | 8.456E-06 | 3.805E-04 | CDK4; CDK2; CDK1 |
hsa04914 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.519E-03 | 7.596E-03 | CDK2; CDK1 |
hsa05161 | Hepatitis B_Homo sapiens_hsa05161 | 3.330E-03 | 1.362E-02 | CDK4; CDK2 |
hsa05162 | Measles_Homo sapiens_hsa05162 | 2.897E-03 | 1.304E-02 | CDK4; CDK2 |
hsa05168 | Herpes simplex infection_Homo sapiens_hsa05168 | 5.285E-03 | 1.982E-02 | CDK2; CDK1 |
hsa05169 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 6.268E-03 | 2.170E-02 | CDK2; CDK1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
C00-D49: Neoplasms | Small-cell lung cancer | C33-C34 | CDK4 |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | CDK2 |
C00-D49: Neoplasms | Breast cancer | C50 | CDK1 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CDK2; AURKB; AURKA; CDK4 |
C00-D49: Neoplasms | Thymoma | C37, D15.0 | CDK2 |
C00-D49: Neoplasms | Mantle cell lymphoma | C81-C86, C85.7, C90.0, C91-C95 | CDK4 |
C00-D49: Neoplasms | Cancer | C00-C96 | CDK2; AURKA; CDK1; CDK4 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Advanced solid tumor | C00-C75, C7A, C7B | AURKA; CDK4 |